Robin Howard W's Form 4 filing
Nektar Therapeutics (NKTR) · filed Dec 19, 2024
- Accession no.
- 0000950170-24-138693
- Filed
- Dec 19, 2024
- Trade date
- Dec 17-18, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $131.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robin Howard WCIK 0001206869 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 | Common Stock | SSaleDisposed | −46,995 | $1.01 | −$47,464.95 | 1,195,710 | Direct | |
| Dec 18, 2024 | Common Stock | SSaleDisposed | −85,035 | $0.99 | −$84,184.65 | 1,110,675 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.